Back to ROIV
Patient Square Capital LP → ROIV
Patient Square Capital LP ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
4
Latest value
$282M
Q3 2026
Peak value
$283.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $177.2M |
| Q1 2026 | $226.2M |
| Q2 2026 | $283.9M |
| Q3 2026 | $282M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $282M | 7.71M | — | — |
| Q2 2026 | $283.9M | 8.02M | — | — |
| Q1 2026 | $226.2M | 8.17M | — | — |
| Q4 2025 | $177.2M | 8.17M | — | — |
Other funds holding ROIV
$1.9B
$1.7B
$1.3B
$1.3B
$1.2B
$1.2B
$1.2B
$1.1B